5017 – DotDiver PmScl
The DotDiver PmScl is a qualitative dot immunoassay for the determination of IgG antibodies against nuclear and cytoplasmic antigens (Jo-1, PL-7, PL-12, SRP, Mi-2, Ku, PM-Scl 100 and Scl-70) in human serum. The DotDiver PmScl is intended as an aid in the diagnosis of systemic autoimmune diseases in conjunction with other clinical and laboratory findings.
Progressive systemic sclerosis (PSS) or systemic scleroderma is an autoimmune disease of connective tissue characterized by slowly progressive fibrosis leading to sclerosis.
Scl-70 autoantibodies are pathognomonic for PSS patients. Polymyositis and dermatomyositis are idiopathic inflammatory muscle disorders with an unknown etiology, however, autoantibodies to t-RNA transferases like Jo-1, PL-7, and PL-12 are found in myositis patients. Antibodies to SRP are also specific markers for Polymyositis. Mi-2 autoantibodies are detected almost exclusively in patients with dermatomyositis. Patients tested positive for Mi-2 have a relatively mild clinical course.
Dot immunoassays are frequently used for the determination of specific antibodies directed against multiple antigens. The test strips are coated with various antigens in consistent intervals. If antibodies are present in the patient´s sample, they bind to the respective antigens. A secondary antibody conjugated with the enzyme alkaline phosphatase detects the generated immune complexes. A colorless substrate is converted into a colored, insoluble product. The signal intensity of the precipitated reaction product is proportional to the antibody activity in the sample.
The DotDiver PmScl is designed for semi-automated use with the DotDiver instrument.
The GA Generic Assays DotDiver2.0 is a fully automated processor of Line and Dot immunoassays. The small footprint renders the device an ideal solution for laboratories with small space. With a unique software design, the device provides a completely hands-free experience for quantitative, semi-quantitative and qualitative testing via repeated diving of the antigen coated strips into the ready to use cartridges. This special setup provides an optimal reaction environment with reduced assay processing and result analysis time for up to 24 different tests or samples simultaneously.
|Indication||Systemic autoimmune diseases|
|Description||Dot immunoassay for the qualitative determination of IgG antibodies against nuclear and cytoplasmic antigens in human serum|
|Format||Test strips coated with Jo-1, PL-7, PL-12, SRP, Mi-2, Ku, PM-Scl 100 and Scl-70|
|Total incubation time||64 min.|
|Sample volume||10 µL serum|
|No. of determinations||24 x 8|